Spironolactone in chronic heart failure:all's well that ends well

J Am Coll Cardiol. 2003 Jan 15;41(2):215-6. doi: 10.1016/s0735-1097(02)02695-5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Evidence-Based Medicine
  • Heart Failure / drug therapy*
  • Humans
  • Mineralocorticoid Receptor Antagonists / adverse effects
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Spironolactone / adverse effects
  • Spironolactone / therapeutic use*

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone